(Reuters) – Brazilian health regulator Anvisa has approved the Covid-19 vaccine produced by Pfizer and BioNTech for children between six months and four years of age. The move expands the availability of the vaccine, which is sold under the Comirnaty brand for adults.

Brazil’s vaccination rates are already among the highest in the world, with almost 90% of the population having received at least one dose, according to the Our World in Data project, which collects official figures from governments around the world. planet.

You might be interested in reading: The European Union supported the Covid-19 booster of the Pfizer vaccine adapted to combat the omicron variant BA.4/5

Brazil on Friday reported 97 deaths across the country from the coronavirus, well below the daily peak of 4,250 recorded in April 2021.

Covid-19 in Brazil | Pfizer’s vaccine approved for immunization of children aged six months to four years